Your session is about to expire
← Back to Search
Pulmonary Rehabilitation for Post-COVID Syndrome (LHC Rehab Trial)
N/A
Recruiting
Research Sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
One or more of the following symptom/signs: Fatigue, Dyspnea, Exercise Intolerance, Post Exertional Malaise and/or Difficulty Breathing
Age >= 18 years old.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
LHC Rehab Trial Summary
This trial will study the effects of a rehabilitation program on patients who have had long-haul COVID-19.
Who is the study for?
Adults who've had COVID-19 at least 12 weeks ago and are experiencing Long Haul COVID with symptoms like fatigue, difficulty breathing, or exercise intolerance. They must be able to do a cardiopulmonary test. Excluded are those in other studies, recently on investigational drugs, unable to perform certain tests, severely desaturating during exercise testing, pregnant/nursing women, recent cancer treatments or significant other diseases.Check my eligibility
What is being tested?
The study is comparing the effects of virtual versus on-site pulmonary rehabilitation programs for Long Haul COVID patients. It aims to evaluate how these programs impact physical health (like lung function), immune response and mental well-being.See study design
What are the potential side effects?
Since this trial involves non-drug interventions (rehabilitation programs), side effects may include typical exercise-related issues such as muscle soreness or shortness of breath but will vary based on individual health conditions.
LHC Rehab Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I experience fatigue, shortness of breath, or difficulty exercising.
Select...
I am 18 years old or older.
Select...
I am 18 years old or older.
Select...
I have had long-term COVID-19 symptoms.
LHC Rehab Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in aerobic capacity (Peak Oxygen Uptake, Anaerobic Threshold and Maximum Work rate) at 10 weeks after a comprehensive (normal intensity) pulmonary rehabilitation program.
Secondary outcome measures
Change in Anxiety scores
Change in Depression scores
Change in General Quality of Life
+5 moreLHC Rehab Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: No PEMExperimental Treatment1 Intervention
Patients who do not experience Post Exertional Malaise (PEM) will receive 10 weeks of traditional pulmonary rehabilitation.
Group II: + PEMActive Control1 Intervention
Patients who experience Post Exertional Malaise (PEM) will receive 10 weeks of virtual rehabilitation.
Find a Location
Who is running the clinical trial?
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterLead Sponsor
101 Previous Clinical Trials
46,261 Total Patients Enrolled
1 Trials studying COVID-19
600 Patients Enrolled for COVID-19
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I experience fatigue, shortness of breath, or difficulty exercising.I experience fatigue, shortness of breath, or difficulty exercising.I am 18 years old or older.You are unable to do breathing and exercise tests properly.Your oxygen levels drop below 80% during exercise tests.I don't have any major health issues that could affect my study participation.It has been over 12 weeks since I first had COVID-19.You can take a test to check how well your heart and lungs are working together.I am 18 years old or older.It has been over 12 weeks since I had COVID.I've had surgery, radiation, or chemo for cancer in the last 2 years.I am a woman who can have children and am not using effective birth control.I have had long-term COVID-19 symptoms.You can do a test to check how well your heart and lungs work together.I have recently completed or am currently in a lung rehab program.
Research Study Groups:
This trial has the following groups:- Group 1: No PEM
- Group 2: + PEM
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new participants currently being recruited for this research?
"Affirmative. According to clinicaltrials.gov, this research project is actively recruiting as of May 28th 2022, with 40 participants sought after at a single site since its inception on February 2nd 2022."
Answered by AI
How many individuals are participating in this research endeavor?
"Affirmative. The clinicaltrials.gov website has information attesting that this medical trial is actively recruiting participants, first posted on February 2nd 2022 and most recently edited on May 28th 2022. This study needs to enroll 40 patients from 1 centre in total."
Answered by AI
Am I eligible to partake in this experimentation?
"This clinical trial, seeking 40 individuals between 18 and 90 years old afflicted with COVID-19, has a few qualifications that need to be met: lengthy SARS-CoV-2 infection (either documented by PCR or reported), 12 weeks since original diagnosis of the illness, fatigue, dyspnea, exercise intolerance/post exertional malaise/difficulty breathing and capacity for cardiopulmonary exercise testing."
Answered by AI
Does the enrollment criteria encompass individuals of more advanced age?
"According to the trial's inclusion criteria, prospective participants must fall between 18 and 90 years of age. The database currently houses 132 trials specifically for patients younger than 18 while 881 are catered towards adults aged 65 or more."
Answered by AI
Who else is applying?
What state do they live in?
Nebraska
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger